missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human Proprotein Convertase 7/PCSK7 Protein, CF
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
Brand: R&D Systems™ 2984-SE-010
374.94 EUR valid until 2024-12-16
Use promo code "21630" to get your promotional price.
This item is not returnable.
View return policy
Description
Measured by its ability to cleave the fluorogenic peptide substrate pERTKR-AMC (Catalog # ES013 ). The specific activity is >125 pmol/min/μg, as measured under the described conditions.Specifications
| Q16549 | |
| Supplied as a 0.2 μm filtered solution in Tris, NaCl, CaCl2 and Glycerol. | |
| M.W. (Observed): 79 kDa, reducing conditions; M.W. (theoretical): 70 kDa (pro form) & 59 kDa (mature form) | |
| 10 μg | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 6 months from date of receipt, -20°C to -70°C as supplied. 3 months, -20°C to -70°C under sterile conditions after opening. | |
| PCSK7 | |
| Recombinant | |
| Proprotein Convertase 7/PCSK7 |
| Enzyme Activity | |
| 9159 | |
| Proprotein Convertase 7/PCSK7 | |
| Mouse myeloma cell line, NS0-derived human Proprotein Convertase 7/PCSK7 protein Leu38-Thr667, with a 10-His tag between Arg141 and Ser142 | |
| <1.0 EU / 1 μg of the protein by the LAL method. | |
| Unconjugated | |
| >95%, by SDS-PAGE under reducing conditions and visualized by silver stain |